{"id":3250,"date":"2025-01-22T23:31:42","date_gmt":"2025-01-22T23:31:42","guid":{"rendered":"https:\/\/medical-article.com\/?p=3250"},"modified":"2025-01-22T23:31:42","modified_gmt":"2025-01-22T23:31:42","slug":"cancer-biotech-arrivent-lands-an-adc-for-gi-malignancies-and-makes-best-in-class-claim","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=3250","title":{"rendered":"Cancer Biotech ArriVent Lands an ADC for GI Malignancies and Makes Best-in-Class Claim"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2025\/01\/gastrointestinal-gi-cancer-arrivent-biopharma-adc-malignancy-china\/\"><\/a><\/p>\n<p>ArriVent Biopharma claims best-in-class potential in gastrointestinal cancers for its new asset, but it\u2019s not specifying the class. It\u2019s possible the Phase 1-ready drug goes after claudin 18.2, a hot target for GI cancer drug research that recently welcomed its first FDA-approved therapy and is in pursuit by several companies. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2025\/01\/gastrointestinal-gi-cancer-arrivent-biopharma-adc-malignancy-china\/\">Cancer Biotech ArriVent Lands an ADC for GI Malignancies and Makes Best-in-Class Claim<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>ArriVent Biopharma claims best-in-class potential in gastrointestinal cancers for its new asset, but it\u2019s not specifying the class. It\u2019s possible the Phase 1-ready drug goes after claudin 18.2, a hot target for GI cancer drug research that recently welcomed its first FDA-approved therapy and is in pursuit by several companies. The post Cancer Biotech ArriVent&#8230;<\/p>\n","protected":false},"author":0,"featured_media":3251,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-3250","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/3250"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3250"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/3250\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/3251"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}